(Q70401253)
Statements
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial (English)
O Rascol
J L Montastruc
M Simonetta
1 September 1988